Market Highlights
It is estimated that the global Microbiome
Sequencing Services Market Share is expected to register a CAGR ~ 18%
during the forecast period of 2023–2032, with an estimated market value of USD
6.70 Billion in 2032.
Numerous factors such as high investment in next-generation
sequencing, rising genome mapping programs in various countries, and the demand
for microbiome research is anticipated to fuel the growth of the Microbiome
Sequencing Services Market. Moreover, the increasing investments in
next-generation sequencing by various public and private organizations have
created a lucrative option for many companies to invest in providing microbiome
sequencing services, leading to the overall growth of the market. For instance,
according to the data published by the Wall Street Journal in 2016, reported
that venture funding in microbiome firms raised by 458.5% to USD 114.5 million
from 2022 to 2030.
Segmentation
The global microbiome
sequencing services market outlook has been segmented into technology,
application, and end user.
·
The market, based on technology, has been
segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS),
short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
·
The market, by application, has been
further segmented into gastrointestinal diseases, infectious diseases, CNS
diseases, oncology, and others.
·
The market, by end user, has been
segmented into research and academic institutes, pharmaceutical and
biotechnology companies, and others.
Regional Analysis
The market in the Americas is expected to dominate the
global microbiome sequencing services market during the forecast period owing
to the increasing per capita healthcare expenditure, and the heavy adoption of
new technology in the region. Europe is expected to hold the second largest
position in the global microbiome sequencing services market. The market growth
in this region is because of the presence of a well-established healthcare
system and increase in life-threatening diseases. For instance, according to
cancer research UK, there were approximately 9, 921 cases of cancer diagnosed
in 2015. Such high rates of cancer are likely to increase demand for use of
next-generation sequencing as well as increase the market demands for
monoclonal bodies and cellular research. These factors are expected to have a
positive impact on the microbiome sequencing services market. Asia-Pacific is
estimated to be the fastest growing region in the market due to the huge
patient pool of chronic diseases and government initiatives of healthcare
reforms. The market in the Middle East & Africa is likely to account for
the smallest share of the global microbiome sequencing services market. The
market growth in this region owes to the low disposable income in the region.
Key Players
The global microbiome sequencing services market players are
Metabiomics Corp.,
Baseclear B.V.,
Clinical Microbiomics A/S,
EPIBIOME,
Merieux Nutrisciences Corporation,
Microbiome Insights Inc.,
Microbiome Therapeutics, LLC.,
MR DNA,
Rancho Biosciences,
Second Genome,
Ubiome, Inc., and
Zymo Research Corp.
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
United
States of America
